Literature DB >> 8187447

Joint involvement in polymyositis/dermatomyositis.

G Citera1, M A Gõni, J A Maldonado Cocco, E J Scheines.   

Abstract

The frequency and features of joint involvement were evaluated in 29 patients with polymyositis/dermatomyositis (PM/DM); eight of them (27.5%) presented arthritis. Mean age was 30 years, and mean disease duration was 5.3 years. Oligoarthritis was observed in 5 cases, while 3 presented polyarthritis; in most cases arthritis was concurrent with the musculocutaneous picture. On comparing the 8 arthritis patients with the remaining 21, no significant clinical or serological differences were found. However, males predominated in the arthritis group, 75% vs 19% (p < 0.05). Arthritis responded favourably to underlying disease treatment and articular sequelae were not observed.

Entities:  

Mesh:

Year:  1994        PMID: 8187447     DOI: 10.1007/bf02229868

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

3.  High-dose corticosteroid therapy: association with noninflammatory synovial effusions.

Authors:  E V Lally
Journal:  Arthritis Rheum       Date:  1983-10

4.  [Articular manifestations in systemic progressive sclerosis].

Authors:  O D Messina; J A Maldonado Cocco; G G Nasswetter; O M García Morteo
Journal:  Rev Clin Esp       Date:  1985-04       Impact factor: 1.556

5.  Polymyositis in rheumatoid arthritis.

Authors:  D A Pitkeathly; E N Coomes
Journal:  Ann Rheum Dis       Date:  1966-03       Impact factor: 19.103

6.  The nature of joint involvement in progressive systemic sclerosis (diffuse scleroderma).

Authors:  G P RODNAN
Journal:  Ann Intern Med       Date:  1962-03       Impact factor: 25.391

7.  Rheumatoid myositis. Clinical and histologic features and possible pathogenesis.

Authors:  J T Halla; W J Koopman; S Fallahi; S J Oh; R E Gay; R E Schrohenloher
Journal:  Arthritis Rheum       Date:  1984-07

8.  Benign joint effusion associated with glucocorticosteroid therapy.

Authors:  J Weinstein
Journal:  J Rheumatol       Date:  1980 Mar-Apr       Impact factor: 4.666

9.  Muscle biopsy in polymyositis and dermatomyositis: a clinicopathological study.

Authors:  H A Schwarz; G Slavin; P Ward; B M Ansell
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

10.  Dermatopolymyositis and other connective tissue diseases: a review of 105 cases.

Authors:  K E Tymms; J Webb
Journal:  J Rheumatol       Date:  1985-12       Impact factor: 4.666

View more
  1 in total

Review 1.  Arthritis in Idiopathic Inflammatory Myopathies.

Authors:  Martin Klein; Heřman Mann; Jiří Vencovský
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.